Study
MemoVigor 2 May Help Reduce Tinnitus Symptoms in Older Adults
Taking MemoVigor 2 daily for 3 months showed promise in alleviating tinnitus symptoms in seniors.
Hearing HealthHealthy AgingMemory Support
Summary
In plain language
This study explored whether MemoVigor 2, a dietary supplement, could help alleviate symptoms of tinnitus—a persistent ringing in the ears. Seniors with tinnitus participated in a 3-month trial where they were given either MemoVigor 2 or a placebo. The findings suggest that those who took MemoVigor 2 experienced some relief in their tinnitus symptoms. This is encouraging news for seniors seeking alternative options for managing tinnitus, a common issue in older age. It's important to discuss these findings with your healthcare provider to see if this supplement might be beneficial for you.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study investigated the effects of MemoVigor 2 on tinnitus symptoms in older adults. Participants were randomly assigned to take either MemoVigor 2 or a placebo for 3 months. Researchers found that those who took MemoVigor 2 reported an improvement in their symptoms.
The study used a randomized, double-blind design, meaning neither participants nor researchers knew who received the actual supplement.
Key ingredients in MemoVigor 2 include phospholipids, vitamins, and plant extracts like Ginkgo biloba and Bilberry, which may support brain and ear health.
While promising, these results should be considered preliminary and discussed with your healthcare provider before starting any new supplement.
Always consult with your healthcare provider before making changes to your health regimen.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Peer-reviewed publication · Clinical Trial
MemoVigor 2 May Help Reduce Tinnitus Symptoms in Older Adults
Published January 2026 · DOI 10.3389/fphar.2026.1856536
Opens at the publisher · external site · may require institutional access
Research Quality Score
Assessment
The study's strengths include its randomized controlled design with proper blinding and allocation concealment. However, it lacks transparency in reporting and COI disclosure, and the journal quality is unassessable. Statistical methods are not fully detailed, and no replication evidence is provided.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 10.0/10 | |
| Bias & Methods | 10.0/10 | |
| Statistical Integrity | 5.0/10 | |
| Transparency | 5.0/10 | |
| Conflict of Interest Disclosure | 0.0/10 | |
| Replication / External Validation | 0.0/10 | |
| Relevance to Seniors | 10.0/10 | |
| Journal Quality | 0.0/10 |
Additional Notes
The study evaluates the effect of MemoVigor 2 on tinnitus symptoms in older adults using a randomized, placebo-controlled trial design.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were checked.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Treatment Option
Vitamins
Vitamins are essential nutrients that help maintain energy, immunity, and overall vitality. For seniors, daily vitamin support can fill nutritional gaps, strengthen bones, and protect heart and brain health when used safely under professional guidance.
14 studies
Read more →
Treatment Option
Ginkgo Biloba
Ginkgo biloba is an ancient herbal extract used to improve memory, focus, and blood flow. It supports cognitive performance and circulation, particularly in older adults.
11 studies
Read more →
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.